Status:
COMPLETED
Extracorporeal Life Support and Modification of Hemostasis
Lead Sponsor:
University Hospital, Ghent
Conditions:
Bleeding Disorder
Extra Corporeal Life Support
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate change in coagulation tests during a 48-h period after initiation VV-ECMO and VA-ECMO. (ECMO= Extra Corporeal Membrane Oxygenator) Assessment of bleeding during Veno-Venous Extracoporeal ...
Detailed Description
This is a multi-center, prospective, pilot cohort study, performed in the Intensive Care Units (ICUs) of the Ghent University Hospital, CHU Liège, University Hospital Brussels, and University Hospital...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- GROUP 1: patients who will be initiated on VV-ECMO within a 12-h period
- GROUP 2: patients who will be initiated on VA-ECMO within a 12-h period
- ≥ 18 years
- Signed Informed Consent, signed by subject or authorized representative
- Exclusion criteria:
- Expected survival \<48-h Known coagulopathy Pregnancy
Exclusion
Key Trial Info
Start Date :
May 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04912336
Start Date
May 28 2021
End Date
April 30 2024
Last Update
July 30 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Charleroi
Lodelinsart, Henegouwen, Belgium, 6042
2
CHU UCL Namur- Godinne
Yvoir, Namen, Belgium, 5530
3
Ghent University Hospital
Ghent, Belgium, 9000
4
University Hospital Brussels
Jette, Belgium, 1090